Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses of Archaea01:29

Viruses of Archaea

639
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
639
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.2K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K
DNA Bacteriophages01:26

DNA Bacteriophages

1.3K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.3K
Vaccine Production01:23

Vaccine Production

30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel approach for vaccine delivery using mRNA lipid nanoparticles for <i>in vivo</i> production of monoclonal antibodies.

Molecular therapy. Nucleic acids·2026
Same author

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications.

Viruses·2025
Same author

Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics.

Biochemical and biophysical research communications·2025
Same author

Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Viral Vector-Based Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Immunobiology and immunotherapy of COVID-19.

Progress in molecular biology and translational science·2025

Related Experiment Video

Updated: Mar 22, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K

Alphavirus-Based Vaccines.

Kenneth Lundstrom1

  • 1PanTherapeutics, Rue des Remparts 4, CH1095, Lutry, Switzerland. lundstromkenneth@gmail.com.

Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
PubMed
Summary
This summary is machine-generated.

Alphavirus vectors show promise for developing vaccines against viral and tumor targets. These vectors have demonstrated effective immune responses and protection in preclinical studies and early human trials.

Keywords:
AlphavirusesCancer vaccinesImmunizationProtectionViral vaccines

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K

Related Experiment Videos

Last Updated: Mar 22, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.3K

Area of Science:

  • Virology
  • Vaccinology
  • Immunology

Background:

  • Alphavirus vectors, derived from Semliki Forest virus, Sindbis virus, and Venezuelan equine encephalitis virus, are established tools in vaccine research.
  • Various formats, including naked RNA replicons, viral particles, and DNA vectors, have been utilized for immunization.

Purpose of the Study:

  • To evaluate the efficacy of alphavirus vectors in preclinical and clinical settings for vaccine development.
  • To assess the potential of these vectors against viral and tumor antigens.
  • To explore their application in combating epidemic alphaviruses like Chikungunya virus.

Main Methods:

  • Immunization of preclinical animal models with alphavirus vectors carrying viral or tumor antigens.
  • Conducting limited clinical trials in human subjects.
  • Evaluating immune responses and protection against viral challenges and tumor cell inoculation.

Main Results:

  • Alphavirus vector vaccination elicited potent immune responses.
  • Demonstrated significant protection against lethal viral challenges.
  • Showed efficacy in preclinical models against tumor cells.
  • Vaccines developed against epidemic alphaviruses like Chikungunya virus.

Conclusions:

  • Alphavirus vectors are effective platforms for vaccine development against diverse targets.
  • They induce robust immunity and provide protection in preclinical and clinical studies.
  • Potential exists for broader application, including against emerging alphavirus threats.